Portfolio Manager Details His Top Pick: Pinnacle Foods (NYSE:PF)
Chief Investment Officer of Fund Management Group has recently revealed his top picks for 2017.
Based on years of award winning market research and detailed financial analysis, Owen Fitzpatrick has money making stocks and clear investment advice on how to avoid money losing portfolio picks.
The top pick? “What Pinnacle Foods (NYSE:PF) has been able to do is move in the direction of healthier types of offerings. They’ve done that largely through the Birds Eye division, but they have also gone out and made acquisitions like Boulder Brands.”
To help investors, Owen Fitzpatrick has come up with these hot recommendations:
“We think Envision is kind of in the sweet spot of that trend. They have three different divisions. I would say two out of the three really are ones that the whole health care system is likely going to benefit from, one being these ambulatory surgery centers.”
“A company that we’ve owned for years is Celgene. Celgene’s biggest drug by far is REVLIMID, to treat blood cancers and multiple myeloma. The run rate in terms of revenue base for this drug is over $7 billion.”
For a free report and the other top recommendations from the in depth interview with Owen Fitzpatrick, Lead Portfolio Manager and Senior Research Analyst at Aristotle Atlantic Partners, visit TWST.com.
# # #
NOTE TO INVESTORS AND FINANCIAL NEWS EDITORS: Owen Fitzpatrick, Lead Portfolio Manager and Senior Research Analyst at Aristotle Atlantic Partners is available for interviews. Contact Aristotle Atlantic Partners, LLC at www.aristotlecap.com
– See more at https://www.twst.com/interview/applying-bottom-up-fundamental-research-in-the-large-cap-space
